Two Arm Open Label Pilot Study of Flibanserin (Addyi) vs. Flibanserin and Sex Therapy

Trial Profile

Two Arm Open Label Pilot Study of Flibanserin (Addyi) vs. Flibanserin and Sex Therapy

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs Flibanserin (Primary)
  • Indications Female sexual dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jan 2017 Planned End Date changed from 1 Jan 2018 to 1 Mar 2018.
    • 16 Jan 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2017.
    • 16 Jan 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top